At least 10 percent of people who have a heart attack may have undiagnosed diabetes, according to new research presented at the American Heart Association's Quality of Care and Outcomes Research Scientific Sessions 2014.
Researchers studied data on 2,854 heart attack patients who did not have a known diagnosis of diabetes in 24 U.S. hospitals to understand the prevalence and recognition of undiagnosed diabetes. They tested the patients' A1C levels, which is a standard test to determine blood sugar levels for the past 2-3 months.
Diabetes, which causes blood sugar to reach dangerous levels, significantly raises the risk for heart attack. Two out of three people with diabetes die from cardiovascular disease, according to the American Heart Association statistics.
"Diagnosing diabetes in patients who have had a heart attack is important because of the role diabetes plays in heart disease," said Suzanne V. Arnold, M.D., M.H.A., the study's lead author and assistant professor at Saint Luke's Mid America Heart Institute and the University of Missouri at Kansas City. "By recognizing and treating diabetes early, we may be able to prevent additional cardiovascular complications through diet, weight loss and lifestyle changes in addition to taking medications. Another important reason to diagnose diabetes at the time of heart attack is that it can guide the treatments for the patient's coronary artery disease."
People who have a heart attack should ask for a diabetes test if they have a family history of the disease or other risk factors such as overweight/obesity, physical inactivity, and high blood pressure. Those already diagnosed with diabetes should also ask for more information on the disease and how to manage it.
Co-authors are Joshua M. Stolker, M.D.; Kasia J. Lipska, M.D., M.H.S.; Yan Li, Ph.D.; John A. Spertus, M.D., M.P.H.; Darren K. McGuire, M.D., M.Sc.; Silvio E. Inzucchi, M.D.; Abhinav Goyal, M.D., M.H.S.; Thomas M. Maddox, M.D., M.Sc.; Marcus Lind, M.D.; Supriya Shore, M.D.; and Mikhail Kosiborod, M.D. Author disclosures are on the abstract.
The National Institutes of Health, National Heart, Lung, and Blood Institute and Genentech Inc. funded the study.
NOTE: Presentation is 11:45 a.m. ET Tuesday, June 3, 2014.
Statements and conclusions of study authors presented at American Heart Association scientific meetings are solely those of the study authors and do not necessarily reflect the association's policy or position. The association makes no representation or guarantee as to their accuracy or reliability. The association receives funding primarily from individuals; foundations and corporations (including pharmaceutical, device manufacturers and other companies) also make donations and fund specific association programs and events. The association has strict policies to prevent these relationships from influencing the science content. Revenues from pharmaceutical and device corporations are available at http://www.heart.org/corporatefunding.
For Media Inquiries: (214) 706-1173
Michael Burton: (214) 706-1236; email@example.com
Cathy Lewis: (214) 706-1324; firstname.lastname@example.org
Julie Del Barto (broadcast): (214) 706-1330; email@example.com
For Public Inquiries: (800) AHA-USA1 (242-8721)
http://www.heart.org and http://www.strokeassociation.org
AAAS and EurekAlert! are not responsible for the accuracy of news releases posted to EurekAlert! by contributing institutions or for the use of any information through the EurekAlert! system.